Connect for Cancer Prevention Study (Connect)
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT04609072
- Status
- Recruiting
Conditions
- Cancer
- General Research Use
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - 70 Years
- Healthy Volunteers
- Accepted
Study Details
Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of people affected by cancer. By taking part in Connect, participants can help researchers learn how the way we live, our genetics, and our health history may affect cancer risk. Objective: To study and better understand the causes of cancer and to find new ways to prevent it. Eligibility: The study will include 200,000 adults who get their health care from a partner health care system, are between 30 and 70 years old at enrollment, and have never had cancer. People remain eligible to join if they have or once had non-melanoma skin cancer, or a condition that may raise cancer risk (such as ductal carcinoma in situ, or DCIS). Design: Eligible recruits can sign up for Connect online by creating an account on MyConnect using their email address or phone number. After creating an account, they will complete the informed consent process. All information shared through MyConnect is secure to protect participant privacy. After joining the study, participants will be asked to answer online health surveys a few times a year, donate samples of blood, urine, and saliva every two to three years, and safely share access to their electronic health records with Connect. In the future, participants may donate unused samples that are collected at clinical visits, like tissue, stool, or blood, and may mail in samples collected at home. Participants may also share information from personal health trackers, like wearable devices or apps. This information will help researchers study the health and behavior patterns that may affect cancer risk. It takes time to understand the causes of cancer, so Connect will go on for many years. The longer people participate, the more researchers may learn. Participants can leave the study at any time. Learn more about Connect by visiting cancer.gov/connectstudy.
Key Dates
- Start date
- Jul 26, 2021
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2070
- Completion
- Dec 31, 2070
Study Design
- Enrollment
- 200,000 participants (estimated)
Arms
- Arm: Healthy volunteersUp to 200,000 men and women aged 30 to 70 years, with no personal history of cancer, and patients or members of participating integrated health care systems.
Primary Outcome Measure
cancer incidence, progression, and mortality [ Time Frame: year one and onward ]
Central Contacts
- Nicolas A Wentzensen, M.D.(866) 462-6621
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kaiser Permanente Colorado | Denver | Colorado | 80247 | - |
| Kaiser Permanente Georgia | Atlanta | Georgia | 30305 | - |
| Kaiser Permanente Hawaii | Honolulu | Hawaii | 96814 | - |
| University of Chicago Medical Center | Chicago | Illinois | 60603 | - |
| Henry Ford Health Systems | Detroit | Michigan | 48202 | - |
| HealthPartners | Minneapolis | Minnesota | 55425 | - |
| Kaiser Permanente Northwest | Portland | Oregon | 97086 | - |
| Sanford Health | Sioux Falls | South Dakota | 57117 | - |
| Baylor Scott and White Health | Dallas | Texas | 75246 | - |
| Marshfield Clinic Health System | Marshfield | Wisconsin | 54449 | - |
Find similar trials in Denver, CO
Related Studies
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- Long-Term Follow-Up of Recipient of Gene Transfer ResearchRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Caris Biorepository Research ProtocolRecruiting · Caris Science, Inc. · Mobile, Alabama
- Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-upRecruiting · Center for Biomedical Research, LLC · Jacksonville, Florida